Higgins KA
,
Simone CB 2nd
,
Amini A
,
Chetty IJ
,
Donington J
,
Edelman MJ
,
Chun SG
,
Kestin LL
,
Movsas B
,
Rodrigues GB
,
Rosenzweig KE
,
Slotman BJ
,
Rybkin II
,
Wolf A
,
Chang JY
American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC
J Thorac Oncol. 2021 Jan;16(1)
:54-65
PMID:
33011389
URL:
https://www.ncbi.nlm.nih.gov/pubmed/33011389
Abstract
INTRODUCTION: The standard-of-care therapy for extensive-stage SCLC has recently changed with the results of two large randomized trials revealing improved survival with the addition of immunotherapy to first-line platinum or etoposide chemotherapy. This has led to a lack of clarity around the role of consolidative thoracic radiation and prophylactic cranial irradiation in the setting of chemoimmunotherapy. METHODS: The American Radium Society Appropriate Use Criteria are evidence-based guidelines for specific clinical conditions that are reviewed by a multidisciplinary expert panel. The guidelines include a review and analysis of current evidence with the application of consensus methodology (modified Delphi) to rate the appropriateness of treatments recommended by the panel for extensive-stage SCLC. RESULTS: Current evidence supports either prophylactic cranial irradiation or surveillance with magnetic resonance imaging every 3 months for patients without evidence of brain metastases. Patients with brain metastases should receive whole-brain radiation with a recommended dose of 30 Gy in 10 fractions. Consolidative thoracic radiation can be considered in selected cases with the recommended dose ranging from 30 to 54 Gy; this recommendation was driven by expert opinion owing to the limited strength of evidence, as clinical trials addressing this question remain ongoing. CONCLUSIONS: Radiation therapy remains an integral component in the treatment paradigm for ES-SCLC.
Notes
1556-1380
Expert Panel Thoracic Malignancies:
Higgins, Kristin A
Simone, Charles B 2nd
Amini, Arya
Chetty, Indrin J
Donington, Jessica
Edelman, Martin J
Chun, Stephen G
Kestin, Larry L
Movsas, Benjamin
Rodrigues, George B
Rosenzweig, Kenneth E
Slotman, Ben J
Rybkin, Igor I
Wolf, Andrea
Chang, Joe Y
Journal Article
United States
J Thorac Oncol. 2021 Jan;16(1):54-65. doi: 10.1016/j.jtho.2020.09.013. Epub 2020 Oct 1.
|